KR102129150B1 - 이사부코나졸 또는 라부코나졸의 제조 방법 - Google Patents

이사부코나졸 또는 라부코나졸의 제조 방법 Download PDF

Info

Publication number
KR102129150B1
KR102129150B1 KR1020157001779A KR20157001779A KR102129150B1 KR 102129150 B1 KR102129150 B1 KR 102129150B1 KR 1020157001779 A KR1020157001779 A KR 1020157001779A KR 20157001779 A KR20157001779 A KR 20157001779A KR 102129150 B1 KR102129150 B1 KR 102129150B1
Authority
KR
South Korea
Prior art keywords
leu
gly
val
ala
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157001779A
Other languages
English (en)
Korean (ko)
Other versions
KR20150037875A (ko
Inventor
숨메렌 뤼벤 판
하리 페쎈
다닐 민크
마리오 바저
Original Assignee
바실리어 파마슈티카 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바실리어 파마슈티카 아게 filed Critical 바실리어 파마슈티카 아게
Publication of KR20150037875A publication Critical patent/KR20150037875A/ko
Application granted granted Critical
Publication of KR102129150B1 publication Critical patent/KR102129150B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020157001779A 2012-08-07 2013-07-31 이사부코나졸 또는 라부코나졸의 제조 방법 Active KR102129150B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12179540.5 2012-08-07
EP12179540 2012-08-07
PCT/EP2013/066071 WO2014023623A1 (en) 2012-08-07 2013-07-31 Process for the manufacture of isavuconazole or ravuconazole

Publications (2)

Publication Number Publication Date
KR20150037875A KR20150037875A (ko) 2015-04-08
KR102129150B1 true KR102129150B1 (ko) 2020-07-02

Family

ID=48979725

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157001779A Active KR102129150B1 (ko) 2012-08-07 2013-07-31 이사부코나졸 또는 라부코나졸의 제조 방법

Country Status (15)

Country Link
US (2) US9783508B2 (enExample)
EP (1) EP2882723B1 (enExample)
JP (1) JP6334529B2 (enExample)
KR (1) KR102129150B1 (enExample)
CN (1) CN104507917B (enExample)
BR (1) BR112015002526B1 (enExample)
CA (1) CA2878361C (enExample)
ES (1) ES2616412T3 (enExample)
HR (1) HRP20170171T1 (enExample)
HU (1) HUE031679T2 (enExample)
MX (1) MX360783B (enExample)
PL (1) PL2882723T3 (enExample)
PT (1) PT2882723T (enExample)
SI (1) SI2882723T1 (enExample)
WO (1) WO2014023623A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801500B (zh) * 2014-12-31 2018-08-24 四川科伦药物研究院有限公司 拆分艾沙康唑中间化合物消旋体的方法
CN106317044A (zh) * 2015-06-30 2017-01-11 刘玫君 一种制造艾沙康唑或雷夫康唑的方法
CN104961695A (zh) * 2015-07-27 2015-10-07 成都塞恩斯医药科技有限公司 一种艾沙康唑和雷夫康唑中间体的制备方法
CN106467534B (zh) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 一种硫酸艾沙康唑鎓化合物及其药物组合物
CN105907832B (zh) * 2015-12-02 2019-07-12 成都师范学院 一种酶法拆分艾沙康唑中间体的方法
CN108452848B (zh) * 2016-02-24 2020-12-11 上海兰立生物科技有限公司 一种催化剂
SG11201909712TA (en) 2017-04-27 2019-11-28 Codexis Inc Ketoreductase polypeptides and polynucleotides
WO2021245590A1 (en) * 2020-06-04 2021-12-09 Metrochem Api Private Limited An improved process for the preparation of triazole derivatives
CN111574444A (zh) * 2020-07-07 2020-08-25 安徽贝克生物制药有限公司 一种贝达喹啉的制备方法
CN116478103B (zh) * 2023-03-24 2025-07-25 四川澄华生物科技有限公司 一种拆分艾沙康唑中间体4的方法
CN119661453B (zh) * 2025-02-17 2025-04-22 四川澄华生物科技有限公司 一种制备艾沙康唑的主链中间体的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510195D0 (en) * 1985-04-22 1985-05-30 Ici Plc Heterocyclic compounds
US5134152A (en) 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
JP2887523B2 (ja) * 1990-11-30 1999-04-26 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
GB9107055D0 (en) 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
JP4208269B2 (ja) * 1996-10-01 2009-01-14 東芝ソリューション株式会社 異種物混入検査方法及びそのシステム
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds
WO1999045008A1 (en) 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
AU2002321068B2 (en) * 2001-06-26 2007-11-15 Basilea Pharmaceutica Ag Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
US7816537B2 (en) 2005-12-01 2010-10-19 Basilea Pharmaceutica Ag Process for the manufacture of epoxybutanol intermediates
GB0712972D0 (en) 2007-07-04 2007-08-15 Glaxosmithkline Consumer Healt Formulation
JP5553354B2 (ja) 2007-07-04 2014-07-16 ディーエスエム アイピー アセッツ ビー.ブイ. エステラーゼの調製
CA2699152C (en) 2007-09-12 2015-11-24 Activx Biosciences, Inc. Spirocyclic aminoquinolones as gsk-3 inhibitors
WO2009157418A1 (ja) * 2008-06-25 2009-12-30 第一三共株式会社 カルボン酸化合物
MX2011000179A (es) * 2008-07-03 2011-04-05 Astellas Pharma Inc Derivado de triazol o su sal.
WO2010122175A1 (en) 2009-04-24 2010-10-28 Dsm Ip Assets B.V. Improved pig liver esterases
US8207352B2 (en) 2009-10-08 2012-06-26 Drug Process Licensing Associates LLC Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
WO2011145669A1 (ja) * 2010-05-19 2011-11-24 大日本住友製薬株式会社 アミド誘導体

Also Published As

Publication number Publication date
PT2882723T (pt) 2017-02-23
ES2616412T3 (es) 2017-06-13
KR20150037875A (ko) 2015-04-08
JP2015527345A (ja) 2015-09-17
WO2014023623A1 (en) 2014-02-13
MX2015000744A (es) 2015-04-14
PL2882723T3 (pl) 2017-05-31
US20190077771A1 (en) 2019-03-14
EP2882723B1 (en) 2016-11-16
US10590092B2 (en) 2020-03-17
JP6334529B2 (ja) 2018-05-30
CA2878361A1 (en) 2014-02-13
CA2878361C (en) 2020-09-22
HUE031679T2 (en) 2017-07-28
CN104507917B (zh) 2017-10-17
BR112015002526A2 (pt) 2018-06-12
US20150239852A1 (en) 2015-08-27
BR112015002526B1 (pt) 2022-09-06
CN104507917A (zh) 2015-04-08
HRP20170171T1 (hr) 2017-04-07
MX360783B (es) 2018-11-16
EP2882723A1 (en) 2015-06-17
US9783508B2 (en) 2017-10-10
SI2882723T1 (sl) 2017-04-26

Similar Documents

Publication Publication Date Title
KR102129150B1 (ko) 이사부코나졸 또는 라부코나졸의 제조 방법
US9061991B2 (en) Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
US9139513B2 (en) Process for preparing lacosamide
CA2449836C (fr) Preparation stereoselective de l-acides amines cycliques
JP5973459B2 (ja) ネビボロールの調製のための方法
JP6039710B2 (ja) L−アミノ酸の製造方法
US7232925B2 (en) Process for producing (4E)-5-chloro-2-isopropyl-4-pentenoate and optically active form thereof
CN110343734B (zh) 一种l-草铵膦化学酶法生产方法
JP3140549B2 (ja) α−置換カルボン酸の光学異性体の分離法
US20210087592A1 (en) Enzymatic processes for the preparation of (±)-2-(difluoromethyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid and (±)-2-(vinyl)-1-(alkoxycarbonyl)-cyclopropanecarboxylic acid
US20100297711A1 (en) Process for the synthesis of fosinopril and intermediates thereof
KR101742477B1 (ko) 라세믹 트레오닌으로부터 d-트레오닌 및 호모알라닌을 순차적으로 생산하는 방법
WO2003085120A1 (en) PROCESS FOR PRODUCING EITHER OPTICALLY ACTIVE N-SUBSTITUTED ß-AMINO ACID AND OPTICALLY ACTIVE N-SUBSTITUTED ß-AMINO ACID ESTER OR OPTICALLY ACTIVE N-SUBSTITUTED 2-HOMOPIPECOLIC ACID AND OPTICALLY ACTIVE N-SUBSTITUTED 2-HOMOPIPECOLIC ACID ESTER
JPH06192221A (ja) 光学活性な1−(4−t−ブチルフェニル)−5−オキソ−3−ピロリジンカルボン酸の製造方法
JPWO2008129873A1 (ja) S体選択性フェニルアラニンアミノムターゼ、これをコードするDNA及び(S)−β−フェニルアラニンの製造方法並びに(S)−β−フェニルアラニン類似体の製造方法
EP3461900A1 (en) Method for the preparation of chiral alpha haloalkanoic acids

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150122

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180730

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20191019

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20200329

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20200625

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20200625

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240422

Start annual number: 5

End annual number: 5